Comparative proteinuria management of different angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for normotensive patients with CKD: a Bayesian network meta-analysis
Background Both angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are blood pressure-lowering agents, but they are also being used to control proteinuria in early chronic kidney disease (CKD) patients. However, clinically, some patients present merely proteinu...
Main Authors: | Huizhen Ye, Zhihao Huo, Peiyi Ye, Guanqing Xiao, Zhe Zhang, Chao Xie, Yaozhong Kong |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2020-03-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/8575.pdf |
Similar Items
-
Comparative efficacy of different renin angiotensin system blockade therapies in patients with IgA nephropathy: a Bayesian network meta-analysis of 17 RCTs
by: Zhihao Huo, et al.
Published: (2021-07-01) -
Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Withdrawal Is Associated with Higher Mortality in Hospitalized Patients with COVID-19
by: Emilia Roy-Vallejo, et al.
Published: (2021-06-01) -
Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular events in patients with heart failure: a meta-analysis of randomized controlled trials
by: Chenhui Tai, et al.
Published: (2017-10-01) -
Clinical features of hypertensive patients with COVID-19 compared with a normotensive group: Single-center experience in China
by: Wang Shuang, et al.
Published: (2021-03-01) -
Proteinuria: pathophysiology, diagnostic and therapeutic approach
by: Enrico Valvo
Published: (2013-04-01)